[Nicotinic acetylcholine receptor in Alzheimer's disease].

Koji Abe

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)


Nicotinic acetylcholine receptor (nAChR) mediates pleiotropic actions in brain not only for nicotinic neurotransmission but also glutamatergic, dopaminergic, norepinephrinergic, GABAergic, and serotonergic transmissions, especially through allosteric potentiating ligand (APL) action. Because nAChR is rich in thalamus, the direct stimulation of nAChR through APL action is expected to show increasing function of cerebral cortex and limbic system through thalamic activation. In fact, a choline esterase inhibitor with this APL action such as galantamine exerts both cognitive and affective improvements which is called dual benefit for Alzheimer's disease patients.

Original languageEnglish
Pages (from-to)743-750
Number of pages8
JournalNihon rinsho. Japanese journal of clinical medicine
Issue number4
Publication statusPublished - Apr 2013

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of '[Nicotinic acetylcholine receptor in Alzheimer's disease].'. Together they form a unique fingerprint.

Cite this